Company Overview of Vacunek S.L
Vacunek S.L, a biotechnology company, provides biotechnological products to detect pathogens. The company’s products include AberpestiAR-VK, which detects bovine viral diarrhoea virus, border disease virus, and classical swine fever; MyxunAR-VK that is for myxomatosis virus in the rabbit; ParaTBKuanti-VK, which is for paratuberculosis in cattle, sheep and rabbits; and Hegazin-VK that is for bird flu virus A and sub-types H5/H7). The company also involves in the development, production, and marketing of diagnostic kits for infectious diseases. Vacunek S.L is based in Derio, Spain.
Bizkaiko Teknologi Parkea
Ibaizabal Bidea 800
34 615 70 00 36
34 944 03 06 09
Key Executives for Vacunek S.L
Similar Private Companies By Industry
|A.S.A.C. Pharmaceutical I.A.E.||Europe|
|ABAC Therapeutics SA||Europe|
|Adan Medical Innovation, S.L.||Europe|
|Advanced In Vitro Cell Technologies S.A.||Europe|
|Advanced Marker Discovery, S.L.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Vacunek S.L, please visit www.vacunek.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.